161 related articles for article (PubMed ID: 34496154)
21. Oxaliplatin-induced gamma-H2AX activation via both p53-dependent and -independent pathways but is not associated with cell cycle arrest in human colorectal cancer cells.
Chiu SJ; Lee YJ; Hsu TS; Chen WS
Chem Biol Interact; 2009 Dec; 182(2-3):173-82. PubMed ID: 19735649
[TBL] [Abstract][Full Text] [Related]
22. PRIMA-1Met suppresses colorectal cancer independent of p53 by targeting MEK.
Lu T; Zou Y; Xu G; Potter JA; Taylor GL; Duan Q; Yang Q; Xiong H; Qiu H; Ye D; Zhang P; Yu S; Yuan X; Zhu F; Wang Y; Xiong H
Oncotarget; 2016 Dec; 7(50):83017-83030. PubMed ID: 27806324
[TBL] [Abstract][Full Text] [Related]
23. Anti-Colon Cancer Effects of 6-Shogaol Through G2/M Cell Cycle Arrest by p53/p21-cdc2/cdc25A Crosstalk.
Qi LW; Zhang Z; Zhang CF; Anderson S; Liu Q; Yuan CS; Wang CZ
Am J Chin Med; 2015; 43(4):743-56. PubMed ID: 26119958
[TBL] [Abstract][Full Text] [Related]
24. The synthetic flavonoid WYC02-9 inhibits colorectal cancer cell growth through ROS-mediated activation of MAPK14 pathway.
Chen YJ; Chen HP; Cheng YJ; Lin YH; Liu KW; Chen YJ; Hou MF; Wu YC; Lee YC; Yuan SS
Life Sci; 2013 Jun; 92(22):1081-92. PubMed ID: 23624232
[TBL] [Abstract][Full Text] [Related]
25. Bortezomib Stabilizes and Activates p53 in Proliferative Compartments of Both Normal and Tumor Tissues
Xue Y; Barker N; Hoon S; He P; Thakur T; Abdeen SR; Maruthappan P; Ghadessy FJ; Lane DP
Cancer Res; 2019 Jul; 79(14):3595-3607. PubMed ID: 31138526
[TBL] [Abstract][Full Text] [Related]
26. The labdane diterpene sclareol (labd-14-ene-8, 13-diol) induces apoptosis in human tumor cell lines and suppression of tumor growth in vivo via a p53-independent mechanism of action.
Mahaira LG; Tsimplouli C; Sakellaridis N; Alevizopoulos K; Demetzos C; Han Z; Pantazis P; Dimas K
Eur J Pharmacol; 2011 Sep; 666(1-3):173-82. PubMed ID: 21620827
[TBL] [Abstract][Full Text] [Related]
27. Chemotherapy-induced
Wang F; Zhao L; Zhang J; Meng Z; Zhou C; Wang G; Liu Y; Li M; Xi J; Niu W; Wang G
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30429233
[TBL] [Abstract][Full Text] [Related]
28. Scutellarin suppresses growth and causes apoptosis of human colorectal cancer cells by regulating the p53 pathway.
Yang N; Zhao Y; Wang Z; Liu Y; Zhang Y
Mol Med Rep; 2017 Feb; 15(2):929-935. PubMed ID: 28035355
[TBL] [Abstract][Full Text] [Related]
29. Protein kinase d as a potential chemotherapeutic target for colorectal cancer.
Wei N; Chu E; Wipf P; Schmitz JC
Mol Cancer Ther; 2014 May; 13(5):1130-41. PubMed ID: 24634417
[TBL] [Abstract][Full Text] [Related]
30. Cooperation of SRPK2, Numb and p53 in the malignant biology and chemosensitivity of colorectal cancer.
Wang G; Sheng W; Tang J; Li X; Zhou J; Dong M
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31898732
[TBL] [Abstract][Full Text] [Related]
31. Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer.
Alzoubi S; Brody L; Rahman S; Mahul-Mellier AL; Mercado N; Ito K; El-Bahrawy M; Silver A; Boobis A; Bell JD; Hajji N
Oncotarget; 2016 Jul; 7(28):44505-44521. PubMed ID: 27283986
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin.
Faruk M; Ibrahim S; Aminu SM; Adamu A; Abdullahi A; Suleiman AM; Rafindadi AH; Mohammed A; Iliyasu Y; Idoko J; Saidu R; Randawa AJ; Musa HS; Ntekim A; Shah KZ; Abubakar S; Adoke KU; Manko M; Awasum CA
PLoS One; 2021; 16(1):e0245581. PubMed ID: 33465114
[TBL] [Abstract][Full Text] [Related]
33. A Novel Inhibitor Targets Both Wnt Signaling and ATM/p53 in Colorectal Cancer.
Cheng J; Dwyer M; Okolotowicz KJ; Mercola M; Cashman JR
Cancer Res; 2018 Sep; 78(17):5072-5083. PubMed ID: 30032112
[TBL] [Abstract][Full Text] [Related]
34. Cepharanthine exhibits a potent anticancer activity in p53-mutated colorectal cancer cells through upregulation of p21Waf1/Cip1.
Rattanawong A; Payon V; Limpanasittikul W; Boonkrai C; Mutirangura A; Wonganan P
Oncol Rep; 2018 Jan; 39(1):227-238. PubMed ID: 29138869
[TBL] [Abstract][Full Text] [Related]
35. 53BP1 loss induces chemoresistance of colorectal cancer cells to 5-fluorouracil by inhibiting the ATM-CHK2-P53 pathway.
Yao J; Huang A; Zheng X; Liu T; Lin Z; Zhang S; Yang Q; Zhang T; Ma H
J Cancer Res Clin Oncol; 2017 Mar; 143(3):419-431. PubMed ID: 27838786
[TBL] [Abstract][Full Text] [Related]
36. 8-Cl-adenosine-induced inhibition of colorectal cancer growth in vitro and in vivo.
Carlson CC; Chinery R; Burnham LL; Dransfield DT
Neoplasia; 2000; 2(5):441-8. PubMed ID: 11191111
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer.
Zhang Y; Talmon G; Wang J
Cell Death Dis; 2015 Aug; 6(8):e1845. PubMed ID: 26247730
[TBL] [Abstract][Full Text] [Related]
38. EBF1-Mediated Upregulation of Ribosome Assembly Factor PNO1 Contributes to Cancer Progression by Negatively Regulating the p53 Signaling Pathway.
Shen A; Chen Y; Liu L; Huang Y; Chen H; Qi F; Lin J; Shen Z; Wu X; Wu M; Li Q; Qiu L; Yu N; Sferra TJ; Peng J
Cancer Res; 2019 May; 79(9):2257-2270. PubMed ID: 30862720
[TBL] [Abstract][Full Text] [Related]
39. Quinacrine synergizes with 5-fluorouracil and other therapies in colorectal cancer.
Gallant JN; Allen JE; Smith CD; Dicker DT; Wang W; Dolloff NG; Navaraj A; El-Deiry WS
Cancer Biol Ther; 2011 Aug; 12(3):239-51. PubMed ID: 21725213
[TBL] [Abstract][Full Text] [Related]
40. Combination of cabazitaxel and p53 gene therapy abolishes prostate carcinoma tumor growth.
Tamura RE; Lana MG; Costanzi-Strauss E; Strauss BE
Gene Ther; 2020 Feb; 27(1-2):15-26. PubMed ID: 30926960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
